# Ryder System Inc: Form 10-Q for the period ended Sep 30, 2026

- Company: [Ryder System Inc](/companies/r.md) (CIK 85961)
- Form: 10-Q
- Filed: 2026-10-22
- Accepted by EDGAR: Oct 22, 2026, 16:56 ET
- Period: 2026-09-30
- Accession: 0001628280-26-066919
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/85961/000162828026066919/r-20260930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/85961/000162828026066919/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2026-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2026-07-01 to 2026-09-30 | $3.43bn | us-gaap:Revenues |
| Revenue | 9 months, 2026-01-01 to 2026-09-30 | $9.91bn | us-gaap:Revenues |
| Selling, general and administrative | 3 months, 2026-07-01 to 2026-09-30 | $375.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2026-01-01 to 2026-09-30 | $1.15bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months, 2026-07-01 to 2026-09-30 | $96.0m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2026-01-01 to 2026-09-30 | $290.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2026-07-01 to 2026-09-30 | $64.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2026-01-01 to 2026-09-30 | $140.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2026-07-01 to 2026-09-30 | $162.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2026-01-01 to 2026-09-30 | $388.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2026-07-01 to 2026-09-30 | $4.15 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2026-01-01 to 2026-09-30 | $9.86 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2026-07-01 to 2026-09-30 | $4.21 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2026-01-01 to 2026-09-30 | $9.97 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2026-07-01 to 2026-09-30 | 38,791,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2026-01-01 to 2026-09-30 | 39,103,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2026-01-01 to 2026-09-30 | $1.99bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2026-01-01 to 2026-09-30 | $1.38bn | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 9 months, 2026-01-01 to 2026-09-30 | $113.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2026-01-01 to 2026-09-30 | $372.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2026-09-30 | $198.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2026-09-30 | $2.60bn | us-gaap:AssetsCurrent |
| Total assets | at 2026-09-30 | $16.17bn | us-gaap:Assets |
| Current liabilities | at 2026-09-30 | $3.88bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2026-09-30 | $13.19bn | us-gaap:Liabilities |
| Current portion of debt | at 2026-09-30 | $1.67bn | us-gaap:DebtCurrent |
| Shareholders' equity | at 2026-09-30 | $2.98bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2026-09-30 | 38,218,715 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 2,127 characters.

The following table provides information with respect to purchases we made of our common stock during the three months ended September 30, 2026:

*(Dollars in millions, except per share)*

|  | Total Number of Shares Purchased (1) | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Programs | Aggregate Maximum Number of Shares That May Yet Be Purchased Under the Discretionary and Anti-Dilutive Programs (2) |
| --- | ---: | ---: | ---: | ---: |
| July 1 through July 31, 2026 | **49,827** | **$263.15** | **49,827** | **2,824,654** |
| August 1 through August 31, 2026 | **105,108** | **256.97** | **105,108** | **2,719,546** |
| September 1 through September 30, 2026 | **870** | **238.71** | **—** | **2,719,546** |
| Total | **155,805** | **$258.85** | **154,935** |  |

*(1) During the three months ended September 30, 2026, we purchased an aggregate of 870 shares of our common stock in employee-related transactions. Employee-related transactions may include: (i) shares of common stock withheld as payment for the exercise price of options exercised or to satisfy the tax withholding liability associated with our share-based compensation programs and (ii) open-market purchases by the trustee of Ryder’s deferred compensation plans relating to investments by employees in our stock, one of the investment options available under the plans.*

*(2) We maintain two share repurchase programs approved by our board of directors in October 2025 and May 2026. Refer to Note 10, “Share Repurchase Programs,” in the Notes to Condensed Consolidated Financial Statements for a discussion on our share repurchase programs. Share repurchases under both programs can be made from time to time using our working capital and a variety of methods, including open-market transactions and trading plans established pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934. The timing and actual number of shares repurchased are subject to market conditions, legal requirements and other factors, including balance sheet leverage, availability of quality acquisitions and stock price.*

## Market risk

As filed, 213 characters.

There have been no material changes to Ryder's exposures to market risks since December 31, 2025. Please refer to the 2025 Annual Report on Form 10-K for a complete discussion of Ryder's exposures to market risks.

## Controls and procedures

As filed, 1,010 characters.

### Evaluation of Disclosure Controls and Procedures

As of the end of the third quarter of 2026, we carried out an evaluation, under the supervision and with the participation of management, including Ryder's Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of Ryder's disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934). Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that as of the end of the third quarter of 2026, Ryder's disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934) were effective.

### Changes in Internal Control over Financial Reporting

During the three months ended September 30, 2026, there were no changes in Ryder's internal control over financial reporting that have materially affected or are reasonably likely to materially affect such internal control over financial reporting.

## Risk factors

As filed, 510 characters.

To our knowledge and except to the extent additional factual information disclosed in this Quarterly Report on Form 10-Q relates to such risk factors, there have been no material changes in the risk factors described in "Item 1A. Risk Factors" in our Form 10-K for the year ended December 31, 2025, filed with the SEC on February 11, 2026. Our operations could also be affected by additional risk factors that are not presently known to us or by factors that we currently consider not material to our business.

Filed Oct 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-066919. Last ingested by Listed: Nov 3, 2026, 22:29 ET. No prices; not investment advice.